Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1543941

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1543941

Alopecia Drugs

PUBLISHED:
PAGES: 187 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Alopecia Drugs Market to Reach US$15.7 Billion by 2030

The global market for Alopecia Drugs estimated at US$10.8 Billion in the year 2023, is expected to reach US$15.7 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Topical Alopecia Drugs, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$8.4 Billion by the end of the analysis period. Growth in the Oral Alopecia Drugs segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.9 Billion While China is Forecast to Grow at 5.2% CAGR

The Alopecia Drugs market in the U.S. is estimated at US$2.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.5 Billion by the year 2030 trailing a CAGR of 5.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Alopecia Drugs Market - Key Trends and Drivers Summarized

What Is Driving the Rising Demand for Alopecia Treatments?

The demand for alopecia treatments is experiencing a significant surge, driven by increased awareness of hair loss conditions and their impacts on individuals' well-being. Alopecia, which includes types such as androgenetic alopecia (pattern baldness) and alopecia areata (autoimmune-related hair loss), affects millions worldwide. Public awareness campaigns and educational efforts have brought attention to the prevalence and psychological effects of hair loss, prompting more people to seek effective treatments. This heightened awareness extends to healthcare providers, leading to more frequent diagnoses and treatment prescriptions. Additionally, the social stigma surrounding hair loss has diminished, encouraging more individuals to pursue medical solutions without fear of judgment.

How Are Innovations Transforming Alopecia Drug Development?

Innovations in biotechnology have dramatically transformed the development and effectiveness of alopecia drugs. Advances in genetic and molecular research have led to the creation of new drug classes, such as JAK inhibitors and regenerative medicine approaches, which offer more targeted and effective treatments compared to traditional therapies like minoxidil and finasteride. These new treatments promise better outcomes with fewer side effects, enhancing patient compliance and satisfaction. Additionally, improvements in diagnostic tools have enabled earlier and more precise detection of alopecia, allowing for timely intervention with appropriate therapies. The incorporation of personalized medicine into dermatology is also revolutionizing the field, providing treatments tailored to individual genetic profiles and specific types of alopecia.

Which Trends Are Boosting the Adoption of Alopecia Drugs?

Several key trends are boosting the adoption of alopecia drugs, reflecting broader shifts in healthcare and consumer preferences. The rise of personalized medicine and the development of more effective, targeted treatments are major factors driving this trend. Consumers are increasingly seeking therapies that offer higher efficacy and fewer side effects, pushing pharmaceutical companies to innovate continuously. The growth of online pharmacies and telemedicine platforms has also made accessing alopecia treatments more convenient and discreet. Marketing campaigns emphasizing the overall benefits of hair health and the availability of non-invasive treatment options have further spurred demand. Additionally, societal trends towards self-care and aesthetic enhancement have highlighted the importance of addressing hair loss, normalizing and even glamorizing the pursuit of treatment.

What Factors Are Fueling the Growth of the Alopecia Drugs Market?

The growth in the alopecia drugs market is driven by several factors, primarily technological advancements, evolving consumer behaviors, and expanding applications. Technological innovations in drug development, such as the creation of more targeted therapies and regenerative medicine, have significantly enhanced the effectiveness and appeal of alopecia treatments. Evolving consumer behaviors, particularly the increasing demand for personalized and convenient healthcare solutions, have fueled market growth. The rise of telemedicine and online pharmacies has made it easier for patients to obtain prescriptions and treatments, contributing to higher adoption rates. Additionally, strategic collaborations between pharmaceutical companies and research institutions are accelerating the development of innovative therapies. Expanding applications of alopecia drugs, including their use in combination therapies and advanced diagnostic techniques, create new opportunities for market expansion. The increase in disposable incomes and the growing awareness of hair loss treatments in emerging markets further strengthen the business case for premium alopecia drugs.

Select Competitors (Total 28 Featured) -

  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Taisho Pharmaceutical Co., Ltd.
  • The Himalaya Drug Company
Show more
Product Code: MCP10243

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Alopecia Drugs - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness of Alopecia Conditions Throws Spotlight on Alopecia Drugs Market
    • Technological Advancements in Drug Development Propel Growth of Alopecia Treatments
    • Increasing Prevalence of Alopecia Expands Addressable Market Opportunity
    • Here's How Improved Diagnostic Techniques Spur Demand for Alopecia Drugs
    • Growth in Personalized Medicine Drives Adoption of Targeted Alopecia Therapies
    • Innovations in Hair Regeneration Technologies Generate Demand for New Treatments
    • Growth in Dermatology Clinics and Specialized Hair Treatment Centers Expands Addressable Market
    • Increasing Incidence of Stress and Lifestyle-Related Hair Loss Spurs Market Growth
    • Advances in Biotechnology Sustain Growth in Alopecia Drug Development
    • Global Trends towards Aesthetic and Cosmetic Treatments Generate Continuous Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Men by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Men by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Men by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Women by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Women by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Women by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Alopecia Drugs Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Alopecia Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Alopecia Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Alopecia Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Children by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Children by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Children by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Alopecia Totalis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Alopecia Totalis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Alopecia Totalis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Alopecia Areata by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Alopecia Areata by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Alopecia Areata by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Alopecia Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Alopecia Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Other Alopecia Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Alopecia Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Alopecia Drugs by Gender - Men, Women and Children - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Alopecia Drugs by Gender - Men, Women and Children Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men, Women and Children for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Alopecia Drugs by Product Type - Percentage Breakdown of Value Sales for Topical, Oral and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: USA 16-Year Perspective for Alopecia Drugs by Alopecia Type - Percentage Breakdown of Value Sales for Alopecia Totalis, Alopecia Areata and Other Alopecia Types for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Alopecia Drugs by Gender - Men, Women and Children - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Alopecia Drugs by Gender - Men, Women and Children Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men, Women and Children for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Alopecia Drugs by Product Type - Percentage Breakdown of Value Sales for Topical, Oral and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Canada 16-Year Perspective for Alopecia Drugs by Alopecia Type - Percentage Breakdown of Value Sales for Alopecia Totalis, Alopecia Areata and Other Alopecia Types for the Years 2014, 2024 & 2030
  • JAPAN
    • Alopecia Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Alopecia Drugs by Gender - Men, Women and Children - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Alopecia Drugs by Gender - Men, Women and Children Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men, Women and Children for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Alopecia Drugs by Product Type - Percentage Breakdown of Value Sales for Topical, Oral and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Japan 16-Year Perspective for Alopecia Drugs by Alopecia Type - Percentage Breakdown of Value Sales for Alopecia Totalis, Alopecia Areata and Other Alopecia Types for the Years 2014, 2024 & 2030
  • CHINA
    • Alopecia Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 59: China Recent Past, Current & Future Analysis for Alopecia Drugs by Gender - Men, Women and Children - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Alopecia Drugs by Gender - Men, Women and Children Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men, Women and Children for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Alopecia Drugs by Product Type - Percentage Breakdown of Value Sales for Topical, Oral and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: China 16-Year Perspective for Alopecia Drugs by Alopecia Type - Percentage Breakdown of Value Sales for Alopecia Totalis, Alopecia Areata and Other Alopecia Types for the Years 2014, 2024 & 2030
  • EUROPE
    • Alopecia Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Alopecia Drugs by Gender - Men, Women and Children - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Alopecia Drugs by Gender - Men, Women and Children Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men, Women and Children for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Alopecia Drugs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Alopecia Drugs by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Alopecia Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Alopecia Drugs by Product Type - Percentage Breakdown of Value Sales for Topical, Oral and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Alopecia Drugs by Alopecia Type - Percentage Breakdown of Value Sales for Alopecia Totalis, Alopecia Areata and Other Alopecia Types for the Years 2014, 2024 & 2030
  • FRANCE
    • Alopecia Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 80: France Recent Past, Current & Future Analysis for Alopecia Drugs by Gender - Men, Women and Children - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Alopecia Drugs by Gender - Men, Women and Children Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men, Women and Children for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Alopecia Drugs by Product Type - Percentage Breakdown of Value Sales for Topical, Oral and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: France 16-Year Perspective for Alopecia Drugs by Alopecia Type - Percentage Breakdown of Value Sales for Alopecia Totalis, Alopecia Areata and Other Alopecia Types for the Years 2014, 2024 & 2030
  • GERMANY
    • Alopecia Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Alopecia Drugs by Gender - Men, Women and Children - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Alopecia Drugs by Gender - Men, Women and Children Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men, Women and Children for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Alopecia Drugs by Product Type - Percentage Breakdown of Value Sales for Topical, Oral and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Germany 16-Year Perspective for Alopecia Drugs by Alopecia Type - Percentage Breakdown of Value Sales for Alopecia Totalis, Alopecia Areata and Other Alopecia Types for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Alopecia Drugs by Gender - Men, Women and Children - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Alopecia Drugs by Gender - Men, Women and Children Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men, Women and Children for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Alopecia Drugs by Product Type - Percentage Breakdown of Value Sales for Topical, Oral and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Italy 16-Year Perspective for Alopecia Drugs by Alopecia Type - Percentage Breakdown of Value Sales for Alopecia Totalis, Alopecia Areata and Other Alopecia Types for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Alopecia Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 107: UK Recent Past, Current & Future Analysis for Alopecia Drugs by Gender - Men, Women and Children - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Alopecia Drugs by Gender - Men, Women and Children Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men, Women and Children for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Alopecia Drugs by Product Type - Percentage Breakdown of Value Sales for Topical, Oral and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: UK 16-Year Perspective for Alopecia Drugs by Alopecia Type - Percentage Breakdown of Value Sales for Alopecia Totalis, Alopecia Areata and Other Alopecia Types for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Alopecia Drugs by Gender - Men, Women and Children - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Rest of Europe Historic Review for Alopecia Drugs by Gender - Men, Women and Children Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Rest of Europe 16-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men, Women and Children for the Years 2014, 2024 & 2030
    • TABLE 119: Rest of Europe Recent Past, Current & Future Analysis for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Rest of Europe Historic Review for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Rest of Europe 16-Year Perspective for Alopecia Drugs by Product Type - Percentage Breakdown of Value Sales for Topical, Oral and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Rest of Europe 16-Year Perspective for Alopecia Drugs by Alopecia Type - Percentage Breakdown of Value Sales for Alopecia Totalis, Alopecia Areata and Other Alopecia Types for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Alopecia Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Alopecia Drugs by Gender - Men, Women and Children - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Asia-Pacific Historic Review for Alopecia Drugs by Gender - Men, Women and Children Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Asia-Pacific 16-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men, Women and Children for the Years 2014, 2024 & 2030
    • TABLE 128: Asia-Pacific Recent Past, Current & Future Analysis for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Asia-Pacific Historic Review for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Asia-Pacific 16-Year Perspective for Alopecia Drugs by Product Type - Percentage Breakdown of Value Sales for Topical, Oral and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Asia-Pacific 16-Year Perspective for Alopecia Drugs by Alopecia Type - Percentage Breakdown of Value Sales for Alopecia Totalis, Alopecia Areata and Other Alopecia Types for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 134: Rest of World Recent Past, Current & Future Analysis for Alopecia Drugs by Gender - Men, Women and Children - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of World Historic Review for Alopecia Drugs by Gender - Men, Women and Children Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of World 16-Year Perspective for Alopecia Drugs by Gender - Percentage Breakdown of Value Sales for Men, Women and Children for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of World Recent Past, Current & Future Analysis for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of World Historic Review for Alopecia Drugs by Product Type - Topical, Oral and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of World 16-Year Perspective for Alopecia Drugs by Product Type - Percentage Breakdown of Value Sales for Topical, Oral and Other Product Types for the Years 2014, 2024 & 2030
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Alopecia Drugs by Alopecia Type - Alopecia Totalis, Alopecia Areata and Other Alopecia Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Rest of World 16-Year Perspective for Alopecia Drugs by Alopecia Type - Percentage Breakdown of Value Sales for Alopecia Totalis, Alopecia Areata and Other Alopecia Types for the Years 2014, 2024 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!